Fedratinib inhibits ovarian cancer progression by downregulating QPCT expression.

ABSTRACT:

SUBMITTER: Dong Y 

PROVIDER: S-EPMC12521670 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature